Document Detail


Effects of long-term L-thyroxine treatment on endothelial function and arterial distensibility in young adults with congenital hypothyroidism.
MedLine Citation:
PMID:  19903797     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Patients with congenital hypothyroidism (CH) display subclinical abnormalities of the cardiovascular system that are related to unphysiological fluctuations of TSH levels and occur despite careful replacement therapy. DESIGN: The aim of the present case-control study was to evaluate the effects of long-term levothyroxine (l-T(4)) replacement therapy on the vascular district in CH patients by assessing endothelial function with flow-mediated dilation (FMD) and brachial artery distensibility with the measurement of the coefficient of distensibility (DC). METHODS: Thirty-two young adults with CH aged 18.9+/-0.2 years and 32 age- and sex-matched controls underwent brachial Doppler ultrasound examination to measure FMD and DC at the time of the study. Hypothyroidism was diagnosed by neonatal screening, and l-T(4) treatment was initiated within the first month of life. RESULTS: Compared to healthy controls, CH patients had significantly reduced brachial artery reactivity with lower FMD values (8.9+/-5.7 vs 14.1+/-5.1% P=0.003) and decreased vascular distensibility (24.6+/-1.6 vs 27.3+/-3 kPa(-1)x10(-3), P<0.0002). Linear regression analysis revealed that both total and pubertal mean TSH and number of episodes of undertreatment were independent determinants of FMD and DC. Pubertal mean TSH was the best predictor of both FMD and DC (r=0.81 and r=0.87 respectively, P<0.001). CONCLUSIONS: Young adults with CH treated with long-term l-T(4) replacement therapy may have significant impairment of both FMD and DC. Our data suggest that high TSH levels, inadequately corrected by l-T(4) replacement therapy in CH patients especially during puberty, can exert significant effects on the elastic and functional vessel properties.
Authors:
Ugo Oliviero; Antonio Cittadini; Giorgio Bosso; Manuela Cerbone; Antonio Valvano; Donatella Capalbo; Valentina Apuzzi; Fabrizia Calabrese; Teresa Lettiero; Mariacarolina Salerno
Related Documents :
18516527 - Ligasure in total thyroidectomy.
12173807 - Transcervical thymectomy for myasthenia gravis achieves results comparable to thymectom...
9890737 - Adjuvant therapy and long-term management of differentiated thyroid carcinoma.
12771307 - Combined radioguided parathyroidectomy and intravenous vitamin d therapy for the treatm...
19900067 - Costs and health-related quality of life effects of hysterectomy in patients with benig...
8472977 - Oesophageal motor response to reflux is not impaired in reflux oesophagitis.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-11-10
Journal Detail:
Title:  European journal of endocrinology / European Federation of Endocrine Societies     Volume:  162     ISSN:  1479-683X     ISO Abbreviation:  Eur. J. Endocrinol.     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-01-25     Completed Date:  2010-02-17     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9423848     Medline TA:  Eur J Endocrinol     Country:  England    
Other Details:
Languages:  eng     Pagination:  289-94     Citation Subset:  IM    
Affiliation:
Department of Clinical Medicine, University Federico II, 80131 Naples, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Atherosclerosis / epidemiology*
Brachial Artery / drug effects,  physiology,  ultrasonography
Case-Control Studies
Congenital Hypothyroidism / drug therapy*,  epidemiology*
Endothelium, Vascular / drug effects*
Female
Humans
Linear Models
Longitudinal Studies
Male
Puberty / physiology
Risk Factors
Thyroxine / administration & dosage*
Ultrasonography, Doppler
Vasodilation / drug effects
Young Adult
Chemical
Reg. No./Substance:
7488-70-2/Thyroxine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Bevacizumab plus capecitabine as a salvage therapy in advanced adrenocortical carcinoma.
Next Document:  Hypothalamic-pituitary-adrenal axis response to the severity of illness in non-critically ill patien...